Seasonal influenza, Matrix-M® adjuvant
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Shinde, Vivek, Cho, Iksung, Plested, Joyce S., et al.